Sector revisions Cardiol Therapeutics Inc.

Stocks

Market Closed - Toronto S.E. 23:00:00 22/09/2026 +03			5-day change	1st Jan Change
2.670 ^CAD	+1.14%		+3.49%	+103.82%

08-12	Cardiol Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	Cardiol Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	1y. EPS revision	Nbr of analysts
CARDIOL THERAPEUTICS INC.		2
LONZA GROUP AG		23
IQVIA HOLDINGS INC.		18
BEONE MEDICINES AG		28
REVOLUTION MEDICINES, INC.		21
CELLTRION, INC.		22
MEDPACE HOLDINGS, INC.		12
ASCENDIS PHARMA A/S	-	20
EUROFINS SCIENTIFIC SE		14
TEMPUS AI, INC.		18
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.		15
ICON PUBLIC LIMITED COMPANY		16
GENSCRIPT BIOTECH CORPORATION		7
BIO-TECHNE CORPORATION		11
PHARMARON BEIJING CO., LTD.		11
KYMERA THERAPEUTICS, INC.		22
PROTAGONIST THERAPEUTICS, INC.		13
QIAGEN N.V.		15
ABIVAX		7
PRAXIS PRECISION MEDICINES, INC.		19
Average		16
Weighted average by Cap.		19